HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Birgit Hockenjos Selected Research

Birgit Hockenjos Research Topics

Disease

2Hepatocellular Carcinoma (Hepatoma)
01/2020 - 01/2005
2Liver Diseases (Liver Disease)
12/2012 - 06/2004
1Neoplasms (Cancer)
01/2020
1Carcinogenesis
01/2020
1Fibrosis (Cirrhosis)
01/2019
1Liver Cirrhosis (Hepatic Cirrhosis)
01/2019
1Alcoholic Fatty Liver
01/2019
1Hepatitis
12/2012
1Necrosis
12/2012
1Liver Failure
12/2012
1Non-alcoholic Fatty Liver Disease
06/2004
1Chronic Hepatitis (Chronic Active Hepatitis)
06/2004
1Chronic Hepatitis B
06/2004
1Chronic Hepatitis C
06/2004

Drug/Important Bio-Agent (IBA)

2Adenosine Triphosphate (ATP)IBA
01/2020 - 12/2012
1Diethylnitrosamine (N-Nitrosodiethylamine)IBA
01/2020
1Purinergic P2Y2 ReceptorsIBA
01/2020
1Transcription Factors (Transcription Factor)IBA
01/2019
1OsteopontinIBA
01/2019
1Concanavalin AIBA
12/2012
1Indicators and Reagents (Reagents)IBA
12/2012
1Acetaminophen (Paracetamol)FDA LinkGeneric
12/2012
1Suramin (Suramin Sodium)IBA
12/2012
1Purinergic P2 Receptors (ADP Receptor)IBA
12/2012
1Alanine Transaminase (SGPT)IBA
06/2004
1DDBIBA
06/2004

Therapy/Procedure

1Chemoprevention
01/2020
1Injections
12/2012
1Intraperitoneal Injections
12/2012
1Intravenous Injections
12/2012
1Therapeutics
01/2005